Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (291-300 of 333) with videos related to

Pageof 34
Sort By:
Journal of Hepatology|November 5, 2025
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLDMathias Jachs, Paul Thöne, Aitor Odriozola, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2025
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLDYasaman Vali, Anne-Marieke van Dijk, Jenny Lee, et al.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
The New England Journal of Medicine|February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver FibrosisStephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
The New England Journal of Medicine|November 14, 2023
Efficacy and Safety of Elafibranor in Primary Biliary CholangitisKris V Kowdley, Christopher L Bowlus, Cynthia Levy, et al.
Contemporary Clinical Trials|October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseTimothy Hardy, Kristy Wonders, Ramy Younes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated SteatohepatitisArun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Journal of Hepatology|April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementMohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.
Hepatology Communications|February 5, 2024
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statementHannes Hagström, Leon A Adams, Alina M Allen, et al.
Pageof 34

Showing results (291-300 of 333) with videos related to

Sort By:
Pageof 34
Journal of Hepatology|November 5, 2025
Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLDMathias Jachs, Paul Thöne, Aitor Odriozola, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2025
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLDYasaman Vali, Anne-Marieke van Dijk, Jenny Lee, et al.
The Lancet. Gastroenterology & Hepatology|September 26, 2024
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling studyMathias Jachs, Aitor Odriozola, Fanny Turon, et al.
The New England Journal of Medicine|February 7, 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver FibrosisStephen A Harrison, Pierre Bedossa, Cynthia D Guy, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
The New England Journal of Medicine|November 14, 2023
Efficacy and Safety of Elafibranor in Primary Biliary CholangitisKris V Kowdley, Christopher L Bowlus, Cynthia Levy, et al.
Contemporary Clinical Trials|October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseTimothy Hardy, Kristy Wonders, Ramy Younes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated SteatohepatitisArun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Journal of Hepatology|April 12, 2020
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementMohammed Eslam, Philip N Newsome, Shiv K Sarin, et al.
Hepatology Communications|February 5, 2024
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statementHannes Hagström, Leon A Adams, Alina M Allen, et al.
Pageof 34